Ligand validation:3OAX

HTG: heptyl 1-thio-beta-D-glucopyranoside

HTG is a Ligand Of Interest in 3OAX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3OAX_HTG_A_1508	27%	9%	0.243	0.894	2.46	2.01	7	1	1	0	100%	0.98
3OAX_HTG_B_1509	13%	6%	0.277	0.817	2.79	2.27	7	3	1	0	100%	0.99
3OAX_HTG_A_1507	8%	7%	0.349	0.822	2.83	1.99	7	1	0	0	100%	0.99
3OAX_HTG_B_1506	3%	5%	0.416	0.76	2.7	2.54	7	4	2	0	100%	0.99
2HPY_HTG_A_1508	94%	7%	0.068	0.968	2.48	2.29	8	2	1	0	100%	1
3EJD_HTG_A_100	98%	9%	0.031	0.991	3.37	1.11	2	1	0	0	79%	0.7895
3EJE_HTG_A_100	97%	9%	0.036	0.986	3.34	1.2	2	1	0	0	79%	0.7895
5V2C_HTG_O_303	94%	33%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	40%	0.092	0.971	1.13	1.22	2	1	0	0	100%	1
5WS6_HTG_b_628	88%	43%	0.076	0.952	0.91	1.29	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.